
CLSL
NSEPrice History
Investment Checklist
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Trend
Price above all key MAs — strong uptrend
Price Action
Support & Resistance Levels
Volume Analysis
Recent MA Crossovers
Recent Price Gaps
Stop Loss Levels
Fixed Risk
Technical Levels
Moving Averages
Financials
Peer Comparison
Pesticides & AgrochemicalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| UPL Limited | ₹594.75 | +2.22% | 20.4 | ₹50.21K Cr mid Cap | |
| PI Industries Limited | ₹2,607.40 | +0.38% | 30.0 | ₹39.56K Cr mid Cap | |
| Sumitomo Chemical India Limited | ₹513.70 | +6.77% | 44.2 | ₹25.64K Cr small Cap | |
| Bayer Cropscience Limited | ₹4,129.90 | +0.24% | — | ₹20.69K Cr small Cap | |
| Sharda Cropchem Limited | ₹914.75 | +2.49% | 11.8 | ₹8.25K Cr small Cap | |
| NACL Industries Limited | ₹234.56 | +3.86% | 1,118.5 | ₹5.49K Cr small Cap | |
| Dhanuka Agritech Limited | ₹1,045.90 | +0.82% | 16.1 | ₹4.71K Cr small Cap | |
| Rallis India Limited | ₹229.07 | +2.52% | 23.6 | ₹4.45K Cr small Cap | |
| Bhagiradha Chemicals & Industries Limited | ₹295.90 | -1.78% | 215.0 | ₹3.84K Cr small Cap | |
| Bharat Rasayan Limited | ₹1,341.90 | +1.88% | 15.3 | ₹2.23K Cr small Cap | |
| Crop Life Science Limited | ₹47.40 | -1.25% | 12.7 | ₹81 Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 13 Sept 2024 | ANNUAL GENERAL MEETING | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for CLSL
View AllEmcure Pharma divests mRNA business for Rs 139.5 crore to Immunoscript Life Science
Emcure Pharmaceuticals said that its subsidiary at Gennova Biopharmaceuticals has executed a business transfer agreement for transfer of its mRNA business as a going concern on a slump sale basis to Immunoscript Life Science.
Gennova Biopharmaceuticals to transfer its mRNA business to Immunoscript Life Science
Gennova Biopharmaceuticals, a subsidiary of Emcure Pharmaceuticals, has executed a Business Transfer Agreement for transfer of its mRNA business as a going concern on a slump sale basis for a cash consideration of Rs 139.5 crore to Immunoscript Life Science on 10 July2026.

TD Cowen notes short interest shifts in life science tools stocks - Investing.com India
TD Cowen notes short interest shifts in life science tools stocksInvesting.com India